A Sleeping Giant INNDeedOne of my favorite stocks for the next 12-18 months is none other than Innerscope Hearing Technologies. The price of this stock could drop slightly lower in the $0.0002s, or it could slip all the way down to quins ($0.00000). In either case, I will consciously and happily buy it, the whole time.
My reasoning for such a bullish sentiment is based 100% on the chart, but it doesn't hurt that this company has product in Walmart and Best Buy. I don't think there's a ton of other OTC companies that can say that.
Refocusing on the waves... INND is possibly my favorite chart for the next 1 to 2 years. I don't know what news will come, or if any will come at all, but I know I like what I see. At the highest INND could see $10 in 2025, at the lowest, it could break above $1 but fail to sustain support above $2.
These are the only two options in my opinion, $1 and some change or $10-$11. Don't talk to me about outstanding shares, authorized shares, float, market cap or none of that. It'll work itself out if I'm seeing the chart correctly. I was able to call the 99% drop last year. Let's hope that clarity is still on my side.
(The wave type shown here is called an extending diagonal wave. In this formation, Waves 1-5 all grow longer and Wave 4 almost always enters the zone of Wave 1 (unlike with an impulsive motive wave). Diagonal waves can only be seen in Waves 1, A, 5 or C.
Hearing
Sonova Holding AG bearish scenario:The technical figure Descending Triangle can be found in the Swiss company Sonova Holding AG (SOON.vx) at daily chart. Sonova Holding AG is an internationally active Swiss company headquartered in Stäfa that specializes in hearing care (hearing instruments, cochlear implants, wireless communication). It is one of the largest providers in the sector worldwide. The group operates through its core business brands Phonak, Unitron, Hansaton, Advanced Bionics and AudioNova. The Descending Triangle has broken through the support line on 17/06/2022, if the price holds below this level you can have a possible bearish price movement with a forecast for the next 32 days towards 259.20 CHF. Your stop loss order according to experts should be placed at 351.20 CHF if you decide to enter this position.
Sonova said it had faced shortages of microelectronic components towards the end of the first half. The disruptions to the global economy during the pandemic have upset supply chains across continents, causing shortages of goods and services, including microelectronic components used for hearing aid.
Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.
EARS Long Swing-Trade IdeaThe rising reverse wedge pattern highlights common lower support and higher resistance trend.
A pattern has emerged where the price appears to spike on/around the 9th and 21st of the month and the price seems to rise up to the next level of the fibonacci retracement (Support/Resistance).
I would consider taking a long position at the $3.50 level for a potential move up to $6.00 by 22/Mar/2021.
The fibonacci retracement levels are derived from a previous high volume price spike event that occurred on 1/Dec/2020 wherein the highest concentration of volume occurred at the $5.14 - 5.61 price range.
It is probable that a high number of investors are locked in within that price range and may induce more sellers at these levels, thus there will be significant resistance to pass through that price range on the next spike. $6.00 is possible, but $5.50 may be a more realistic price target due to resistance.
I currently have no position in EARS, so this is just my unbiased opinion based on previous stock performance.